Recently on 4th January, 2023 the Philippines Food and Drug Administration (FDA) released a draft guideline for comments i.e; "Guidelines on Frontline Services of the Food and Drug Administration (FDA) in the New Normal".
A new landscape emerged due to the COVID-19 pandemic and this has altered the way people live and work, and now referred to as the “New Normal”.
In recent years, online platforms and virtual communications have become the standard means of transacting, which has led to a streamlined and digital approach to facilitating FDA services.
To accommodate stakeholders in complying with FDA regulations as mobility and health restrictions ease, several options in transacting with the FDA have been developed and adopted.
With the revised guideline, FDA regulated entities and interested stakeholders will have access to frontline services and procedures, further enhancing communication with the Agency.
This revised guideline will apply to all FDA Centers and Offices providing frontline services, such as submission of documentary requirements, general inquiries, customer complaints, and other services.
Click this LINK to know more about the requirements and eloborate details of the on Frontline Services.
Comments